trending Market Intelligence /marketintelligence/en/news-insights/trending/3eq-3lum9zejii-9xe0qha2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Dr. Reddy's COO to retire; former Teva executive named as replacement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Dr. Reddy's COO to retire; former Teva executive named as replacement

India's Dr. Reddy's Laboratories Ltd. said its COO, Abhijit Mukherjee, will retire March 31.

Mukherjee, who served at the generic-drug maker for 15 years, will be replaced by Erez Israeli.

Israeli held several senior positions, including vice president of Asia operations and president and CEO of growth markets during his 23 years at Teva Pharmaceutical Industries Ltd.

He is also the former president and CEO of specialty chemicals-maker Enzymotec Ltd., which was acquired by Frutarom Industries Ltd. earlier this year.